119 related articles for article (PubMed ID: 14744623)
1. Significance of chymase inhibition for prevention of adhesion formation.
Okamoto Y; Takai S; Miyazaki M
Eur J Pharmacol; 2004 Jan; 484(2-3):357-9. PubMed ID: 14744623
[TBL] [Abstract][Full Text] [Related]
2. Chymase inhibitors may prevent postoperative adhesion formation.
Okamoto Y; Takai S; Yamada M; Miyazaki M
Fertil Steril; 2002 May; 77(5):1044-8. PubMed ID: 12009365
[TBL] [Abstract][Full Text] [Related]
3. A single treatment with a specific chymase inhibitor, TY-51184, prevents vascular proliferation in canine grafted veins.
Takai S; Jin D; Sakaguchi M; Miyazaki M
J Pharmacol Sci; 2004 Apr; 94(4):443-8. PubMed ID: 15107585
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of a novel chymase inhibitor, NK3201, prevents peritoneal adhesion formation in hamsters.
Okamoto Y; Takai S; Miyazaki M
Jpn J Pharmacol; 2002 Sep; 90(1):94-6. PubMed ID: 12396033
[TBL] [Abstract][Full Text] [Related]
5. An antiarrhythmic effect of a chymase inhibitor after myocardial infarction.
Jin D; Takai S; Sakaguchi M; Okamoto Y; Muramatsu M; Miyazaki M
J Pharmacol Exp Ther; 2004 May; 309(2):490-7. PubMed ID: 14730006
[TBL] [Abstract][Full Text] [Related]
6. Chymase inhibitor, BCEAB, suppressed peritoneal adhesion formation in hamster.
Okamoto Y; Takai S; Miyazaki M
J Surg Res; 2002 Oct; 107(2):219-22. PubMed ID: 12429178
[TBL] [Abstract][Full Text] [Related]
7. Chymase inhibitor suppresses adhesion formation in a hamster experimental model.
Okamoto Y; Takai S; Miyazaki M
Eur J Pharmacol; 2002 Jan; 435(2-3):265-7. PubMed ID: 11821036
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of adhesion formation after cardiac surgery with a chymase inhibitor in a hamster model.
Soga Y; Takai S; Koyama T; Okamoto Y; Ikeda T; Nishimura K; Miyazaki M; Komeda M
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):72-8. PubMed ID: 14752415
[TBL] [Abstract][Full Text] [Related]
9. Effect of chymase-dependent transforming growth factor beta on peritoneal adhesion formation in a rat model.
Okamoto Y; Takai S; Miyazaki M
Surg Today; 2004; 34(10):865-7. PubMed ID: 15449158
[TBL] [Abstract][Full Text] [Related]
10. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice.
Takato H; Yasui M; Ichikawa Y; Waseda Y; Inuzuka K; Nishizawa Y; Tagami A; Fujimura M; Nakao S
Exp Lung Res; 2011 Mar; 37(2):101-8. PubMed ID: 21128860
[TBL] [Abstract][Full Text] [Related]
11. Development of the chymase inhibitor as an anti-tissue-remodeling drug: myocardial infarction and some other possibilities.
Sukenaga Y; Kamoshita K; Takai S; Miyazaki M
Jpn J Pharmacol; 2002 Nov; 90(3):218-22. PubMed ID: 12499575
[TBL] [Abstract][Full Text] [Related]
12. Significance of chymase-dependent matrix metalloproteinase-9 activation on indomethacin-induced small intestinal damages in rats.
Kakimoto K; Takai S; Murano M; Ishida K; Yoda Y; Inoue T; Jin D; Umegaki E; Higuchi K
J Pharmacol Exp Ther; 2010 Feb; 332(2):684-9. PubMed ID: 19996300
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis.
Takai S; Jin D; Muramatsu M; Okamoto Y; Miyazaki M
Eur J Pharmacol; 2004 Oct; 501(1-3):1-8. PubMed ID: 15464056
[TBL] [Abstract][Full Text] [Related]
14. Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta.
Uehara Y; Urata H; Ideishi M; Arakawa K; Saku K
Cardiovasc Res; 2002 Sep; 55(4):870-6. PubMed ID: 12176136
[TBL] [Abstract][Full Text] [Related]
15. Chymase inhibitor-sensitive synthesis of endothelin-1 (1-31) by recombinant mouse mast cell protease 4 and human chymase.
Semaan W; Desbiens L; Houde M; Labonté J; Gagnon H; Yamamoto D; Takai S; Laidlaw T; Bkaily G; Schwertani A; Pejler G; Levesque C; Desjardins R; Day R; D'Orléans-Juste P
Biochem Pharmacol; 2015 Mar; 94(2):91-100. PubMed ID: 25667044
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of chymase reduces vascular proliferation in dog grafted veins.
Takai S; Yuda A; Jin D; Nishimoto M; Sakagichi M; Sasaki S; Miyazaki M
FEBS Lett; 2000 Feb; 467(2-3):141-4. PubMed ID: 10675526
[TBL] [Abstract][Full Text] [Related]
17. Development of a chymase inhibitor: pharmacological characterization of a chymase inhibitor in inflamed tissue remodeling and fibrosis.
Nakajima M; Naya N
Jpn J Pharmacol; 2002 Nov; 90(3):206-9. PubMed ID: 12499572
[TBL] [Abstract][Full Text] [Related]
18. Pivotal role of mouse mast cell protease 4 in the conversion and pressor properties of Big-endothelin-1.
Houde M; Jamain MD; Labonté J; Desbiens L; Pejler G; Gurish M; Takai S; D'Orléans-Juste P
J Pharmacol Exp Ther; 2013 Jul; 346(1):31-7. PubMed ID: 23596057
[TBL] [Abstract][Full Text] [Related]
19. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas.
Muramatsu M; Katada J; Hattori M; Hayashi I; Majima M
Eur J Pharmacol; 2000 Aug; 402(1-2):181-91. PubMed ID: 10940372
[TBL] [Abstract][Full Text] [Related]
20. Association between the expression of mast cell chymase and intraperitoneal adhesion formation in mice.
Yao YL; Ishihara T; Takai S; Miyazaki M; Mita S
J Surg Res; 2000 Jul; 92(1):40-4. PubMed ID: 10864480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
